In line with diagnosis, after 7 days, patient’s laboratory assessments showed a clear improvement of the clinical conditions and the laboratory findings (Hb 12.8 g/dl, 150.000/ul reticulocytes) confirming the transient nature of erythroblastopenia. The gene discussed is GSTM1; the disease is Erythroid hypoplasia.